Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. - Wikidata - wikimedia - TriplyDB

Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses.

Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses.

http://www.wikidata.org/entity/Q35216178

about

Advances in the Use of Stem Cells in Veterinary Medicine: From Basic Research to Clinical Practice Platelet-rich plasma in orthopedic therapy: a comparative systematic review of clinical and experimental data in equine and human musculoskeletal lesions New and emerging strategies in platelet-rich plasma application in musculoskeletal regenerative procedures: general overview on still open questions and outlook Clinical applications of platelet-rich plasma in patellar tendinopathy Platelet-rich plasma injections for the treatment of refractory Achilles tendinopathy: results at 4 years.Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial The potential role of regenerative medicine in the man-agement of traumatic patients.Leukocyte-poor PRP application for the treatment of knee osteoarthritis.Advantages of Pure Platelet-Rich Plasma Compared with Leukocyte- and Platelet-Rich Plasma in Treating Rabbit Knee Osteoarthritis.Platelet-rich plasma for the treatment of patellar tendinopathy: clinical and imaging findings at medium-term follow-up New bio-ceramization processes applied to vegetable hierarchical structures for bone regeneration: an experimental model in sheep.Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration.Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy--a systematic review.Application of Platelet-Rich Plasma to Disorders of the Knee Joint Platelet-rich plasma to treat ankle cartilage pathology - from translational potential to clinical evidence: a systematic review Mesenchymal stem cells for tendon healing: what is on the horizon?Platelet-rich plasma in tendon-related disorders: results and indications.Platelet-Rich Plasma Intra-articular Knee Injections Show No Superiority Versus Viscosupplementation: A Randomized Controlled Trial.Platelet-rich plasma and hyaluronic acid - an efficient biostimulation method for face rejuvenation.FEASIBILITY FOR ULTRASOUND-GUIDED INJECTION OF THE COLLATERAL LIGAMENTS OF THE DISTAL INTERPHALANGEAL JOINT IN HORSES.Platelet-Rich Plasma Treatment With Physical Therapy in Chronic Partial Supraspinatus Tears.PRP for the treatment of cartilage pathology.Platelet-Rich Plasma: The Choice of Activation Method Affects the Release of Bioactive Molecules.Preparing Platelet-Rich Plasma with Whole Blood Harvested Intraoperatively During Spinal Fusion.Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes?Canine Platelet-Rich Plasma Systems: A Prospective Analysis.Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses.A systematic review of the concept and clinical applications of bone marrow aspirate concentrate in tendon pathology Evaluation of intra-articular injection of autologous platelet lysate (PL) in horses with osteoarthritis of the distal interphalangeal joint.Comments on Torricelli et al.: regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses.Autologous point-of-care cellular therapies variably induce equine mesenchymal stem cell migration, proliferation and cytokine expression.Comparison of platelet counting technologies in equine platelet concentrates.Intra-articular use of a platelet-rich product in normal horses: clinical signs and cytologic responses.Equine autologous platelet concentrates: A comparative study between different available systems.Effects of three blood derived products on equine corneal cells, an in vitro study.Thromboelastographic Clot Characteristics of Autologous Equine Blood Products After Activation by Autologous Thrombin, Bovine Thrombin, or Calcium Chloride.Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know.

P2860

Q26744494-3D688D21-544C-4158-8437-0E9040721801 Q26825183-A94FD0AB-B427-4CEC-86F9-2ED79F85DC5D Q27012858-F3ABFC93-0E1F-476F-B6C1-7B941B3B280F Q34022507-610B18F0-2D43-4D37-920F-8B845E26CF43 Q34416364-9CB5C248-EDA4-4666-802B-D1B0ECC31CB7 Q34486652-C59C4714-E8CD-4705-A49C-3342F0CF6773 Q34884800-2492BA14-6A0C-4F3A-BC61-114D75EBE250 Q34971341-13DAB40A-2ED3-4BFF-BC61-A12D5D98DCA1 Q36816671-4079F1B4-9891-4CE7-AA97-5FA490E7D433 Q37057516-2C0007D1-333D-47BD-BCB9-E4673D27EDE7 Q37590700-8F809A77-6559-42CB-B7F1-4B8895DDE695 Q38042089-494362D9-EDC0-4766-A013-042A0FF171D9 Q38166202-5B6CEDE1-F7B4-4D27-8943-4B616550CD50 Q38260840-A76D9962-B696-4CC8-8220-E6FDE6B26B72 Q38526268-BB4D821A-933E-414A-A7F8-AFB41E117D85 Q38749900-73EE527A-C516-4F42-B602-0EE4078B72C3 Q38946911-F55FF3B5-F8E7-49A5-BACC-733811164B98 Q38963686-CD271FAE-3EF5-408D-923D-5B7791416595 Q39189544-AA5CFD25-E7C0-4B0E-85A7-2A4758DEBCD6 Q39421746-761AAB92-1B11-49AE-90B3-2F66E511DC10 Q40343956-1BAE5902-6A9B-44D9-B40D-145FCC2FF343 Q40425101-19CA90ED-7D8D-4E19-BD0F-C9868F4945B5 Q41059641-5AA7CABE-EB3D-4A8C-A296-72F12FE34DE2 Q41146926-3B15B232-1DD8-48FA-91C5-58DE281F5B28 Q41184009-3E3B54CF-15A0-4C10-AE6B-76BDBE6444AE Q41823550-5333B29D-FD49-4F39-9F99-704CBABB9DC8 Q41879117-8502D5A7-1CB1-4A18-B135-F5A502335B8D Q42368439-D9E4E27A-06D2-4A19-A6BC-90A682036C90 Q42372963-4D0F28AC-2621-421D-BF95-DD04A1A4BA7D Q42488352-1CC5CE1B-5DD7-4F20-88B3-25A87D1F1CF3 Q42940210-CAF0E984-0309-4D3D-A3B6-89E56527083D Q44914168-8E62A243-D3CE-4F20-8E5F-3464E3F22F88 Q45004419-851D7978-1BA3-453C-A7FD-66E7BCC2FB20 Q45187852-0319D1C7-9533-4FB9-B0B5-C9A19A7CB285 Q46936943-955C46FE-8DF5-4372-9835-1127321B5D16 Q48169102-8A1FBFE0-7414-4CA0-9ED8-1B2FE0C2C230 Q51699954-A5EC2CFB-FA18-49C8-9044-95C4B2676BBF Q55344331-C9893E8B-EFF3-4A00-ADE6-E9C5512E9064

P2860

Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses.

http://www.wikidata.org/entity/Q35216178

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Regenerative medicine for the ...... njuries in competition horses.

@ast

Regenerative medicine for the ...... njuries in competition horses.

@en

type

label

Regenerative medicine for the ...... njuries in competition horses.

@ast

Regenerative medicine for the ...... njuries in competition horses.

@en

prefLabel

Regenerative medicine for the ...... njuries in competition horses.

@ast

Regenerative medicine for the ...... njuries in competition horses.

@en

P1433

Q35216178-CAD74166-0FF2-422F-9AB1-F4389EECF856

P1476

Q35216178-67FBC2A4-4873-44E4-B337-893002CD4527

P2093

Q35216178-4FE2BFA6-64F4-476F-8A23-60DF339DC835

Q35216178-9987DBD5-E9C9-4D29-BAE7-C3568B5AEB2E

Q35216178-A6B24273-4CB4-4D52-8847-CAB65DB60B39

Q35216178-BE555671-8CEC-4BA9-BB98-9BA93DF359AB

Q35216178-E43CD32C-CD4D-4B8C-99CB-1BA0643B7877

P2860

Q35216178-062C2DC2-ECEE-4C50-B58D-B6BB2E43B0E8

Q35216178-1CF479BF-F4C4-4DDA-AA31-2C5C8A2D2937

Q35216178-328742B2-31E3-4C36-A89B-45894B5516FA

Q35216178-34899D0D-06C5-411B-9295-7DB686909144

Q35216178-439BD2D9-DDF9-4122-9139-E1CE6C769A40

Q35216178-4977593F-4753-4636-A170-6C9698C592AD

Q35216178-4D6A0B75-B39E-43D8-A7B6-8303BD84F19A

Q35216178-557DA1B4-3E1F-44D6-90C6-8A5C74982A20

Q35216178-5BF0D9A8-6039-4307-9281-3691369CC0DC

Q35216178-75BC07F2-527C-4E88-8C13-893E882D7EF7

P2888

Q35216178-3088CC06-4055-4FD9-892D-843B353892D3

P304

Q35216178-07115F52-FCAC-4CB0-BCAB-9559306BCA07

P31

Q35216178-25DD2CC7-EAF4-474B-8259-62A5D36E4585

P356

Q35216178-67CDFD53-D832-4356-A625-7E28396D3609

P433

Q35216178-129E50D8-8FA2-4EBD-9F30-2AFCD5CA7A64

P478

Q35216178-508ED2F9-74E2-4063-BA4C-FFFF1674282B

P50

Q35216178-503BEA6B-7F02-4A1E-ACC0-91F6EE2BAAB7

Q35216178-A8D66B24-E228-44D3-A25A-4088959AAD92

Q35216178-DD0AB1C4-201C-4BA2-8CE5-EEE9A50F5487

P577

Q35216178-E0A0C9F9-D183-4107-AFEB-2CDB8864744C

P5875

Q35216178-427A529D-40F3-46A2-8C0C-D6420768CAE3

P698

Q35216178-65CCE91D-7747-4BDB-B836-2980BE563765

P932

Q35216178-EEB39D43-4F16-4874-B118-A09FC203871B

P356

S00264-011-1237-3

P1433

International Orthopaedics

P1476

Regenerative medicine for the ...... njuries in competition horses.

@en

P2093

Alessandra Pacorini

http://www.w3.org/2001/XMLSchema#string

Elizaveta Kon

http://www.w3.org/2001/XMLSchema#string

Mario Pischedda

http://www.w3.org/2001/XMLSchema#string

Paola Torricelli

http://www.w3.org/2001/XMLSchema#string

Roberto Giardino

http://www.w3.org/2001/XMLSchema#string

P2860

Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine

Long-term prognosis for jumper's knee in male athletes. A prospective follow-up study

Anthropometry, physical performance, and ultrasound patellar tendon abnormality in elite junior basketball players: a cross-sectional study

Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis.

Tissue regeneration and in loco administration of platelet derivatives: clinical outcome, heterogeneous products, and heterogeneity of the effector mechanisms.

New insights into and novel applications for platelet-rich fibrin therapies.

Regenerative medicine for tendinous and ligamentous injuries of sport horses.

The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair.

Mesenchymal stem cells and tendon healing.

One-step bone marrow-derived cell transplantation in talar osteochondral lesions.

P2888

s00264-011-1237-3

P304

1569-1576

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00264-011-1237-3

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Filardo

P577

2011-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50364915

http://www.w3.org/2001/XMLSchema#string

P698

21394594

http://www.w3.org/2001/XMLSchema#string

P932

3174295

http://www.w3.org/2001/XMLSchema#string